Advanced Therapies in Orthopaedics

Overview

Journal EFORT Open Rev

Specialty Orthopedics

Date 2024 Sep 2

PMID 39222330

Authors

Tobias Winkler

Sven Geissler

Tazio Maleitzke

Carsten Perka

Georg N Duda

Alexander Hildebrandt

Affiliations

Soon will be listed here.

Abstract

Advanced therapies are expected to play a crucial role in supporting repair after injury, halting the degeneration of musculoskeletal tissue to enable and promote physical activity. Despite advancements, the progress in developing advanced therapies in orthopaedics lags behind specialties like oncology, since innovative regenerative treatment strategies fall short of their expectations in musculoskeletal clinical trials. Researchers should focus on understanding the mechanism of action behind the investigated target before conducting clinical trials. Strategic research networks are needed that not only enhance scientific exchange among like-minded researchers but need to include early on commercial views, companies and venture perspectives, regulatory insights and reimbursement perspectives. Only in such collaborations essential roadblocks towards clinical trials and go-to-patients be overcome.

Citing Articles

[University trauma surgery and orthopedics: where is the journey going to?].

Greiser J, Roth A, Bocker W Unfallchirurgie (Heidelb). 2025; 128(1):18-24.

PMID: 39747592 DOI: 10.1007/s00113-024-01517-y.

References

Kholinne E, Singjie L, Marsetio A, Kwak J, Jeon I . Return to physical activities after arthroscopic rotator cuff repair: a systematic review and meta-analysis. Eur J Orthop Surg Traumatol. 2023; 33(6):2645-2654. DOI: 10.1007/s00590-023-03490-5. View

Pantziarka P, Capistrano I R, De Potter A, Vandeborne L, Bouche G . An Open Access Database of Licensed Cancer Drugs. Front Pharmacol. 2021; 12:627574. PMC: 7991999. DOI: 10.3389/fphar.2021.627574. View

Ferraz M . An Overview on the Big Players in Bone Tissue Engineering: Biomaterials, Scaffolds and Cells. Int J Mol Sci. 2024; 25(7). PMC: 11012232. DOI: 10.3390/ijms25073836. View

Colombini A, Libonati F, Lopa S, Peretti G, Moretti M, de Girolamo L . Autologous chondrocyte implantation provides good long-term clinical results in the treatment of knee osteoarthritis: a systematic review. Knee Surg Sports Traumatol Arthrosc. 2022; 31(6):2338-2348. DOI: 10.1007/s00167-022-07030-2. View

DeJulius C, Walton B, Colazo J, dArcy R, Francini N, Brunger J . Engineering approaches for RNA-based and cell-based osteoarthritis therapies. Nat Rev Rheumatol. 2024; 20(2):81-100. PMC: 11129836. DOI: 10.1038/s41584-023-01067-4. View

De La Vega R, van Griensven M, Zhang W, Coenen M, Nagelli C, Panos J . Efficient healing of large osseous segmental defects using optimized chemically modified messenger RNA encoding BMP-2. Sci Adv. 2022; 8(7):eabl6242. PMC: 8849297. DOI: 10.1126/sciadv.abl6242. View

Petersen A, Princ A, Korus G, Ellinghaus A, Leemhuis H, Herrera A . A biomaterial with a channel-like pore architecture induces endochondral healing of bone defects. Nat Commun. 2018; 9(1):4430. PMC: 6202397. DOI: 10.1038/s41467-018-06504-7. View

Peniche Silva C, Muller S, Quirk N, Poh P, Mayer C, Motta A . Enthesis Healing Is Dependent on Scaffold Interphase Morphology-Results from a Rodent Patellar Model. Cells. 2022; 11(11). PMC: 9179925. DOI: 10.3390/cells11111752. View

Reinke S, Geissler S, Taylor W, Schmidt-Bleek K, Juelke K, Schwachmeyer V . Terminally differentiated CD8⁺ T cells negatively affect bone regeneration in humans. Sci Transl Med. 2013; 5(177):177ra36. DOI: 10.1126/scitranslmed.3004754. View

10.

Drzeniek N, Kahwaji N, Schlickeiser S, Reinke P, Geissler S, Volk H . Immuno-engineered mRNA combined with cell adhesive niche for synergistic modulation of the MSC secretome. Biomaterials. 2023; 294:121971. DOI: 10.1016/j.biomaterials.2022.121971. View

11.

van Heerden P, Abutbul A, Sviri S, Zlotnick E, Nama A, Zimro S . Apoptotic Cells for Therapeutic Use in Cytokine Storm Associated With Sepsis- A Phase Ib Clinical Trial. Front Immunol. 2021; 12:718191. PMC: 8515139. DOI: 10.3389/fimmu.2021.718191. View

12.

Ji T, Feng B, Shen J, Zhang M, Hu Y, Jiang A . An Avascular Niche Created by Axitinib-Loaded PCL/Collagen Nanofibrous Membrane Stabilized Subcutaneous Chondrogenesis of Mesenchymal Stromal Cells. Adv Sci (Weinh). 2021; 8(20):e2100351. PMC: 8529489. DOI: 10.1002/advs.202100351. View

13.

Agres A, Alves S, Hontzsch D, El Attal R, Pohlemann T, Schaser K . Improved weight bearing during gait at 6 weeks post-surgery with an angle stable locking system after distal tibial fracture. Gait Posture. 2023; 107:169-176. DOI: 10.1016/j.gaitpost.2023.09.013. View

14.

Kim H, Seo J, Lee Y, Park K, Perry T, Arden N . The current state of the osteoarthritis drug development pipeline: a comprehensive narrative review of the present challenges and future opportunities. Ther Adv Musculoskelet Dis. 2022; 14:1759720X221085952. PMC: 9732806. DOI: 10.1177/1759720X221085952. View

15.

von Roth P, Abdel M, Wauer F, Winkler T, Wassilew G, Diederichs G . Significant muscle damage after multiple revision total hip replacements through the direct lateral approach. Bone Joint J. 2014; 96-B(12):1618-22. DOI: 10.1302/0301-620X.96B12.34256. View

16.

Mamdouhi T, Wang V, Echevarria A, Katz A, Morris M, Zavurov G . A Comprehensive Review of the Historical Description of Spine Surgery and Its Evolution. Cureus. 2024; 16(2):e54461. PMC: 10953613. DOI: 10.7759/cureus.54461. View

17.

Jiang Z, Dalby P . Challenges in scaling up AAV-based gene therapy manufacturing. Trends Biotechnol. 2023; 41(10):1268-1281. DOI: 10.1016/j.tibtech.2023.04.002. View

18.

Wechsler M, Rao V, Borelli A, Anseth K . Engineering the MSC Secretome: A Hydrogel Focused Approach. Adv Healthc Mater. 2021; 10(7):e2001948. PMC: 8035320. DOI: 10.1002/adhm.202001948. View

19.

Dec P, Modrzejewski A, Pawlik A . Existing and Novel Biomaterials for Bone Tissue Engineering. Int J Mol Sci. 2023; 24(1). PMC: 9820083. DOI: 10.3390/ijms24010529. View

20.

Zhang M, Fukushima Y, Nozaki K, Nakanishi H, Deng J, Wakabayashi N . Enhancement of bone regeneration by coadministration of angiogenic and osteogenic factors using messenger RNA. Inflamm Regen. 2023; 43(1):32. PMC: 10280834. DOI: 10.1186/s41232-023-00285-3. View